Literature DB >> 27543332

Signal transmission through the CXC chemokine receptor 4 (CXCR4) transmembrane helices.

Melanie P Wescott1, Irina Kufareva2, Cheryl Paes1, Jason R Goodman1, Yana Thaker1, Bridget A Puffer1, Eli Berdougo1, Joseph B Rucker1, Tracy M Handel2, Benjamin J Doranz3.   

Abstract

The atomic-level mechanisms by which G protein-coupled receptors (GPCRs) transmit extracellular ligand binding events through their transmembrane helices to activate intracellular G proteins remain unclear. Using a comprehensive library of mutations covering all 352 residues of the GPCR CXC chemokine receptor 4 (CXCR4), we identified 41 amino acids that are required for signaling induced by the chemokine ligand CXCL12 (stromal cell-derived factor 1). CXCR4 variants with each of these mutations do not signal properly but remain folded, based on receptor surface trafficking, reactivity to conformationally sensitive monoclonal antibodies, and ligand binding. When visualized on the structure of CXCR4, the majority of these residues form a continuous intramolecular signaling chain through the transmembrane helices; this chain connects chemokine binding residues on the extracellular side of CXCR4 to G protein-coupling residues on its intracellular side. Integrated into a cohesive model of signal transmission, these CXCR4 residues cluster into five functional groups that mediate (i) chemokine engagement, (ii) signal initiation, (iii) signal propagation, (iv) microswitch activation, and (v) G protein coupling. Propagation of the signal passes through a "hydrophobic bridge" on helix VI that coordinates with nearly every known GPCR signaling motif. Our results agree with known conserved mechanisms of GPCR activation and significantly expand on understanding the structural principles of CXCR4 signaling.

Entities:  

Keywords:  G protein; GPCR activation; chemokine receptor; hydrophobic bridge; shotgun mutagenesis

Mesh:

Substances:

Year:  2016        PMID: 27543332      PMCID: PMC5024644          DOI: 10.1073/pnas.1601278113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

Review 1.  Recognition in the face of diversity: interactions of heterotrimeric G proteins and G protein-coupled receptor (GPCR) kinases with activated GPCRs.

Authors:  Chih-chin Huang; John J G Tesmer
Journal:  J Biol Chem       Date:  2011-01-03       Impact factor: 5.157

2.  Crystal structure of metarhodopsin II.

Authors:  Hui-Woog Choe; Yong Ju Kim; Jung Hee Park; Takefumi Morizumi; Emil F Pai; Norbert Krauss; Klaus Peter Hofmann; Patrick Scheerer; Oliver P Ernst
Journal:  Nature       Date:  2011-03-09       Impact factor: 49.962

3.  Biased and constitutive signaling in the CC-chemokine receptor CCR5 by manipulating the interface between transmembrane helices 6 and 7.

Authors:  Anne Steen; Stefanie Thiele; Dong Guo; Lærke S Hansen; Thomas M Frimurer; Mette M Rosenkilde
Journal:  J Biol Chem       Date:  2013-03-14       Impact factor: 5.157

4.  Dimerization of CXCR4 in living malignant cells: control of cell migration by a synthetic peptide that reduces homologous CXCR4 interactions.

Authors:  Jinhai Wang; Liusheng He; Christian A Combs; Gregory Roderiquez; Michael A Norcross
Journal:  Mol Cancer Ther       Date:  2006-10       Impact factor: 6.261

5.  Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.

Authors:  N Zhou; Z Luo; J Luo; D Liu; J W Hall; R J Pomerantz; Z Huang
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

6.  Identification of CXCR4 domains that support coreceptor and chemokine receptor functions.

Authors:  B J Doranz; M J Orsini; J D Turner; T L Hoffman; J F Berson; J A Hoxie; S C Peiper; L F Brass; R W Doms
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

7.  Comparison of the potential multiple binding modes of bicyclam, monocylam, and noncyclam small-molecule CXC chemokine receptor 4 inhibitors.

Authors:  Rebecca S Y Wong; Veronique Bodart; Markus Metz; Jean Labrecque; Gary Bridger; Simon P Fricker
Journal:  Mol Pharmacol       Date:  2008-09-02       Impact factor: 4.436

8.  A conserved aromatic lock for the tryptophan rotameric switch in TM-VI of seven-transmembrane receptors.

Authors:  Birgitte Holst; Rie Nygaard; Louise Valentin-Hansen; Anders Bach; Maja S Engelstoft; Pia S Petersen; Thomas M Frimurer; Thue W Schwartz
Journal:  J Biol Chem       Date:  2009-11-17       Impact factor: 5.157

9.  Leu128(3.43) (l128) and Val247(6.40) (V247) of CXCR1 are critical amino acid residues for g protein coupling and receptor activation.

Authors:  Xinbing Han; Souvenir D Tachado; Henry Koziel; William A Boisvert
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

10.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

View more
  44 in total

1.  Structure of CC Chemokine Receptor 5 with a Potent Chemokine Antagonist Reveals Mechanisms of Chemokine Recognition and Molecular Mimicry by HIV.

Authors:  Yi Zheng; Gye Won Han; Ruben Abagyan; Beili Wu; Raymond C Stevens; Vadim Cherezov; Irina Kufareva; Tracy M Handel
Journal:  Immunity       Date:  2017-06-20       Impact factor: 31.745

2.  Dynamins 2 and 3 control the migration of human megakaryocytes by regulating CXCR4 surface expression and ITGB1 activity.

Authors:  Praveen K Suraneni; Seth J Corey; Michael J Hession; Rameez Ishaq; Arinola Awomolo; Shirin Hasan; Chirag Shah; Hui Liu; Amittha Wickrema; Najet Debili; John D Crispino; Elizabeth A Eklund; Yolande Chen
Journal:  Blood Adv       Date:  2018-12-11

Review 3.  cAMP guided his way: a life for G protein-mediated signal transduction and molecular pharmacology-tribute to Karl H. Jakobs.

Authors:  Klaus Aktories; Peter Gierschik; Dagmar Meyer Zu Heringdorf; Martina Schmidt; Günter Schultz; Thomas Wieland
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-05-17       Impact factor: 3.000

4.  Functional anatomy of the full-length CXCR4-CXCL12 complex systematically dissected by quantitative model-guided mutagenesis.

Authors:  Bryan S Stephens; Tony Ngo; Irina Kufareva; Tracy M Handel
Journal:  Sci Signal       Date:  2020-07-14       Impact factor: 8.192

5.  VLA-4 phosphorylation during tumor and immune cell migration relies on its coupling to VEGFR2 and CXCR4 by syndecan-1.

Authors:  Oisun Jung; DeannaLee M Beauvais; Kristin M Adams; Alan C Rapraeger
Journal:  J Cell Sci       Date:  2019-10-28       Impact factor: 5.285

Review 6.  What Do Structures Tell Us About Chemokine Receptor Function and Antagonism?

Authors:  Irina Kufareva; Martin Gustavsson; Yi Zheng; Bryan S Stephens; Tracy M Handel
Journal:  Annu Rev Biophys       Date:  2017-05-22       Impact factor: 12.981

Review 7.  Structural basis of chemokine and receptor interactions: Key regulators of leukocyte recruitment in inflammatory responses.

Authors:  Ram Prasad Bhusal; Simon R Foster; Martin J Stone
Journal:  Protein Sci       Date:  2019-10-24       Impact factor: 6.725

Review 8.  Structural insights into emergent signaling modes of G protein-coupled receptors.

Authors:  Ieva Sutkeviciute; Jean-Pierre Vilardaga
Journal:  J Biol Chem       Date:  2020-06-22       Impact factor: 5.157

Review 9.  Chemokines and their receptors: insights from molecular modeling and crystallography.

Authors:  Irina Kufareva
Journal:  Curr Opin Pharmacol       Date:  2016-07-25       Impact factor: 5.547

10.  Deciphering collaborative sidechain motions in proteins during molecular dynamics simulations.

Authors:  Bruck Taddese; Antoine Garnier; Hervé Abdi; Daniel Henrion; Marie Chabbert
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.